HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianying Tang Selected Research

Atherosclerosis

11/2013Phosphoinositide 3-kinase δ/γ inhibition does not prevent concanavalin A-induced hepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jianying Tang Research Topics

Disease

4Infections
08/2015 - 01/2013
1Adenocarcinoma
01/2020
1Cross Infection (Nosocomial Infection)
02/2016
1Pneumonia (Pneumonitis)
02/2016
1Hepatitis
11/2013
1Necrosis
11/2013
1Asthma (Bronchial Asthma)
11/2013
1Atherosclerosis
11/2013

Drug/Important Bio-Agent (IBA)

3Linezolid (Zyvox)FDA Link
08/2015 - 01/2013
1Long Noncoding RNAIBA
01/2020
1VaccinesIBA
02/2016
1O Antigens (O Antigen)IBA
02/2016
1Phosphates (Orthophosphate)IBA
08/2015
1Amino AcidsFDA Link
09/2014
1Phosphatidylinositols (Phosphatidylinositol)IBA
11/2013
1Concanavalin AIBA
11/2013
1Transaminases (Aminotransferases)IBA
11/2013

Therapy/Procedure

1Catheters
11/2014